FNYS
CPXX

First New York Securities’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

First New York Securities’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-252,691
Closed -$7.63M – 341
2016
Q2 		$7.63M Buy
+252,691
New +$5.13M 4.69% 6

First New York Securities's CPXX Position: Q3 2016 in Review

First New York Securities sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 252,691 shares — an estimated $7.63M sold.

First New York Securities first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $7.63M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • First New York Securities reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • First New York Securities sold 252,691 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $7.63M.
  • First New York Securities first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • First New York Securities's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $7.63M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on First New York Securities's 13F filing for Q3 2016, filed 18 Oct 2016.